David E. Moller

31.5k citations
168 papers · 25.6k · 8 hit papers · h-index 72

Impact in

Papers in

    • Metabolism, Diabetes, and Cancer 65
    • Peroxisome Proliferator-Activated Receptors 61
    • Protein Kinase Regulation and GTPase Signaling 13
    • Receptor Mechanisms and Signaling 12
    • Adipose Tissue and Metabolism 51

David E. Moller

165 papers receiving 24.9k citations

David E. Moller's Hit Papers

The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes 2013 · 736 citations
7360+10+20Years since publication10002.0k3.0k4.0k

Peers

David E. Moller
Comparison fields: 5 of 152
  • Endocrinology, Diabetes and Metabolism 4.7k
  • Physiology 6.0k
  • Molecular Biology 15.6k
  • Biochemistry 1.4k
  • Endocrine and Autonomic Systems 897
Replace Michael Czech with:
Michael Czech United States
George L. King United States
Fabienne Foufelle France
Marc Prentki Canada
Jean‐Charles Fruchart France
Amira Klip Canada
Gary D. Lopaschuk Canada
Louis M. Havekes Netherlands
Marc Foretz France
Sander Kersten Netherlands
David E. Moller relative to Michael Czech United States Michael Czech's profile →
Citations per field
00.5×1.5×
Michael Czech · 1×
Citations per year

Countries citing papers authored by David E. Moller

Since Specialization
Citations

This map shows the geographic impact of David E. Moller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Moller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Moller more than expected).

Fields of papers citing papers by David E. Moller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Moller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Moller. The network helps show where David E. Moller may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Moller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Moller Line = papers co-authored together David E. Moller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 168 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Role of AMP-activated protein kinase in mechanism of metformin action
Hit paper breakdown →
20014523
2
The Mechanisms of Action of PPARs
Hit paper breakdown →
20022162
3
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Hit paper breakdown →
2008894
4
New drug targets for type 2 diabetes and the metabolic syndrome
Hit paper breakdown →
2001870
5
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Hit paper breakdown →
2013736
6
Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes
Hit paper breakdown →
2002673
7
Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Hit paper breakdown →
2000582
8
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Hit paper breakdown →
1996561
9 1999499
10 2004498
11 2002498
12 2001400
13 2006380
14 1996340
15 1999336
16 2003294
17 1996276
18 2003273
19 1990273
20 2000270

About David E. Moller

David E. Moller is a scholar working on Molecular Biology, Physiology, Surgery, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 168 papers that have together received 25.6k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (65 papers), Peroxisome Proliferator-Activated Receptors (61 papers), Adipose Tissue and Metabolism (51 papers), Pancreatic function and diabetes (31 papers), Adipokines, Inflammation, and Metabolic Diseases (20 papers), Diabetes Treatment and Management (14 papers), Protein Kinase Regulation and GTPase Signaling (13 papers) and Receptor Mechanisms and Signaling (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.7k citations), Physiology (6.0k citations), Molecular Biology (15.6k citations), Biochemistry (1.4k citations) and Endocrine and Autonomic Systems (897 citations). David E. Moller has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Joel P. Berger, Gaochao Zhou, Thomas W. Doebber, Jeffrey S. Flier, Laurie J. Goodyear, Margaret Wu, John Ventre, Yuli Chen, Michael F. Hirshman and Nicolas Musi. Their work appears in journals such as Journal of Biological Chemistry, Diabetes, Endocrinology, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact